Tilray Brands (TLRY) Total Debt (QoQ) (2018 - 2026)
Tilray Brands (TLRY) Total Debt (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Tilray Brands | 541.05 Mn | 306.41 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -9.09% |
| Feb 28, 2026 | -2.05% |
| Nov 30, 2025 | -3.02% |
| Aug 31, 2025 | -1.85% |
| Nov 30, 2024 | -3.91% |
| Aug 31, 2024 | -1.69% |
| May 31, 2024 | -29.16% |
| Feb 29, 2024 | -16.30% |
| Nov 30, 2023 | -26.36% |
| Aug 31, 2023 | 29.79% |
| May 31, 2023 | 13.81% |
| Feb 28, 2023 | -18.03% |
| Nov 30, 2022 | 87.04% |
| Aug 31, 2022 | -3.94% |
| May 31, 2022 | -2.97% |
| Feb 28, 2022 | -10.63% |
| Nov 30, 2021 | -5.41% |
| Aug 31, 2021 | -0.76% |
| Sep 30, 2018 | -74.75% |